Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: ADV/HSV-tk (gene therapy)
Total 0 results
Nothing found
Sponsors and Collaborators
Michael Scharl
Robert Pendleton
Stanford's Innovative Medicines Accelerator
Genesis Foundation
Daqiao Community Health Service Center of Yangpu District
Azumio Inc.
Prostate Cure Foundation
AVAX Technologies
Julie Lefevere
Manresana de Micobacteriologia, SL
National Institute of Drug Abuse
National Institute of Diabetes and Endocrinology, Egypt
University Mental Health Research Institute, Athens, Greece
Health Factors Inc
Rotem Petranker
Spokane Regional Health District
Ondine Biomedical Inc.
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Ancon Technologies Ltd
Montera Health Texas LLC
View Full List
Medical Conditions
Universal Adhesive
Vital Signs
Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Peripheral Artery Calcification
Thymoglobulin Dose
Desmoid
Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
Age of Probands 18 - 55 Years
Immunochromatographic
Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
Connective Active Program
Acute Myocardial Infarction With ST Segment Elevation
Unwanted Abdomen Fat
Convalescent Plasma for COVID 19
Pain Due to Childhood Vaccination
Simulation Training, Laparoscopy
Isolation of Enterococci From Samples
Glanzmann's Thrombasthenia
Skin Burn Multiple
Ischemic Stroke, Cryptogenic
View Full List
Drug Interventions
Formulation N3
Single dose of vepdegestrant as tablet formulation (Treatment A)
GM-CSF
Megestrol Acetate 160 MG
JNJ 10229570-AAA 3.6% cream
Administration of etoricoxib
Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
Golcadomide
Colchicine group (experimental arm)
G-CSF
Mild sedation and analgesia
Glycopyrrolate
Uprifosbuvir
DKN-01
PD-0332991
Nab-paclitaxel
Human menopausal gonadotropin
Ciclesonide
Treament C
Bevacizumab
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Austria
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cameroon
Contract Research Organizations in Egypt
Contract Research Organizations in Ghana
Contract Research Organizations in Guinea
Contract Research Organizations in Jamaica
Contract Research Organizations in Malta
Contract Research Organizations in Netherlands
Contract Research Organizations in Pakistan
Contract Research Organizations in Poland
Contract Research Organizations in Saudi Arabia
CRO list by country
CROs in Sweden
ProPharma Group
NDA Regulatory Science (NDA Group)
Theradex Oncology AB
Astrom Research International
OPIS
A+ Science
Smerud Medical Research Group
Syneos Health
IRW Consulting
ICON
All CROs in Sweden
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe